|
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information
- Taking IMBRUVICA® | IMBRUVICA® (ibrutinib)
Find IMBRUVICA® (ibrutinib) dosing information and helpful tips for adding it to your routine and keeping track of treatments See full Prescribing Safety Information
- IMBRUVICA® Side Effects - CLL SLL | IMBRUVICA® (ibrutinib)
Explore common and serious side effects of IMBRUVICA® (ibrutinib) in treating CLL SLL, including bleeding, infections, and more See full prescribing safety information
- Chronic Lymphocytic Leukemia Treatment - IMBRUVICA
Learn about chronic lymphocytic leukemia (CLL) small lymphocytic lymphoma (SLL) with IMBRUVICA® (ibrutinib) See full prescribing safety information
- WM Treatment | IMBRUVICA® (ibrutinib)
Find important information for patients about IMBRUVICA® (ibrutinib), a treatment for waldenström’s macroglobulinemia (WM) See full Prescribing Safety Information
- How Does IMBRUVICA® Work to Treat CLL SLL
IMBRUVICA® (ibrutinib) blocks BTK to disrupt B-cell signaling and help slow CLL SLL progression See full prescribing safety information
- IMBRUVICA® Side Effects Dosing - WM | IMBRUVICA® (ibrutinib)
View important information about IMBRUVICA® side effects, tips for side effects, and IMBRUVICA® dosage information for WM See full Prescribing Safety Information
- Your Guide to Your IMBRUVICA (ibrutinib) Treatment Plan
IMBRUVICA® may cause serious side effects, including bleeding problems (hemorrhage); infections; heart rhythm problems (ventricular arrhythmias, atrial fibrillation, and atrial flutter); heart failure and death; high blood pressure (hypertension); decrease in blood cell counts; second primary cancers; and tumor lysis syndrome (TLS)
|
|
|